About
Identifai Genetics is developing a noninvasive prenatal test for the early detection of single-gene disorders. Using a simple first-trimester maternal blood test to access the entire embryonic genome, Identifai can perform a comprehensive analysis capable of detecting every single-point mutation, insertion-deletion, and structural variation in order to identify severe genetic disorders. Identifais core suite of algorithms, the Hoobari paradigm, is a patent-pending proprietary methodology developed for five years at Tel Aviv University. The technology has demonstrated high accuracy in detecting a wide variety of mutations in real-life cases, and the company is planning to launch clinical studies. Identifai Genetics is dedicated to providing solutions that will enable safe pregnancies for all families, everywhere.
Funding history · 3 rounds · $9.3M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is IdentifAI Genetics' primary focus?
- IdentifAI Genetics is developing a noninvasive prenatal test for the early detection of single-gene disorders using a first-trimester maternal blood test.
- When was IdentifAI Genetics founded?
- IdentifAI Genetics was founded in November 2020.
- What is the name of IdentifAI Genetics' core suite of algorithms?
- IdentifAI Genetics' core suite of algorithms is called the Hoobari paradigm, which is a patent-pending proprietary methodology developed at Tel Aviv University.
- When did IdentifAI Genetics receive its most recent grant?
- In July 2024, IdentifAI Genetics received a grant of $1,000,000 from the IIA.
- What was IdentifAI Genetics' last funding round?
- IdentifAI Genetics closed a Seed funding round in April 2023, raising $3,300,000 with eHealth Ventures as a lead investor.
- How many employees does IdentifAI Genetics currently have?
- IdentifAI Genetics currently has 14 employees.
- What is the total amount of funding IdentifAI Genetics has raised?
- IdentifAI Genetics has raised a total of $9,250,000 across its funding rounds.
- What is the current product stage for IdentifAI Genetics?
- IdentifAI Genetics' product, Windrose, is currently in the clinical trial stage.
- Which organization supported IdentifAI Genetics with grants in 2023 and 2024?
- The IIA (Israel Innovation Authority) supported IdentifAI Genetics with grants in February 2023 ($2,500,000) and July 2024 ($1,000,000).